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Objective: to analyze the effects of hyaluronic acid of different molecular weights in an
experimental  model of osteoarthritis in rabbits.
Methods: forty-four male California rabbits were divided randomly into three groups and
underwent  resection of the anterior cruciate ligament in his right knee. After three weeks
of  the surgical procedure began three weekly intra-articular injections of hyaluronic acid
native (Polireumin®)-PR, hyaluronic acid branched chain (Synvisc®)-S and 0.9% saline-P. All
animals  were sacriﬁced after twelve weeks of surgery and tibial plateau inﬁltrated the knees
were  dissected. Histological cartilage of the support areas of the tibial plateaus were stained
with  Alcian Blue pH 1.0, Alcian Blue pH = 2.5 and toluidine blue for research on the amount
of  proteoglycans. The intensity of staining was quantiﬁed on a Zeiss microscope apparatus
Imager  Z2 MetaSystems and analyzed by software MetaferMsearch.
Results: the effect of chondroprotetor hyaluronic acids used in the study was conﬁrmed
when  compared to the control group, but the comparison made between them, there was
no  statistically signiﬁcant difference regarding chondroprotetion.
Conclusion: the hyaluronic acids tested had chondroprotective effect, with no statistical dif-
ference with regard to the different molecular weights.
©  2014 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda.  
Efeito  dos  ácidos  hialurônicos  como  condroprotetores  em  modelo
experimental  de  osteoartrose
r  e  s  u  m  o
Este é um artigo Open Access sob a licença de CC BY-NC-NDPalavras chave:
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Ácido  hialurônico
Ligamento cruzado anterior
Objetivo: analisar os efeitos do ácido hialurônico de diferentes pesos moleculares em modelo
experimental  de osteoartrose em coelhos.
Métodos: foram alojados de modo aleatório 44 coelhos da rac¸a  California, machos, em três
grupos  (PR, S e P) e submetidos a ressecc¸ão  do ligamento cruzado anterior do joelho direito.
 Please cite this article as: Oliveira MZ, Albano MB, Namba MM, da Cunha LAM, de Lima Gonc¸alves  RR, Trindade ES, Andrade LF, Vidigal
L. Efeito dos ácidos hialurônicos como condroprotetores em modelo experimental de osteoartrose. Rev Bras Ortop. 2014;49:62–68.
 Study conducted at Department of Orthopedy and Traumatology, Universidade Federal do Paraná, Curitiba, PR, Brazil.
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Joelho
Coelhos
Decorridas três semanas do procedimento cirúrgico iniciaram-se as três injec¸ões  intra-
articulares semanais de ácido hialurônico nativo (Polireumin®)-PR, ácido hialurônico de
cadeia ramiﬁcada (Synvisc®)-S e soro ﬁsiológico 0,9%-P. Todos os animais foram sacriﬁ-
cados após 12 semanas do ato cirúrgico e os platôs tibiais dos joelhos inﬁltrados foram
dissecados. Cortes histológicos da cartilagem das áreas de apoio com maior espessura dos
platôs tibiais foram corados com Alcian Blue pH = 1,0, Alcian Blue Ph = 2,5 e Azul de Toluidina
para pesquisa da quantidade de proteoglicanos. A intensidade de colorac¸ão  foi quantiﬁcada
em um aparelho de microscopia ZeissImager Z2 Metasystems e analisada pelo software
MetaferMsearch. A análise estatística consistiu no uso dos testes Kolmorogov–Smirnov,
análise  de variância (Anova), t de Student e qui-quadrado. O nível de signiﬁcância usado
foi de 5%.
Resultado: o efeito condroprotetor dos ácidos hialurônicos usados no estudo foi demonstrado
quando comparado ao do grupo controle, porém, feita a comparac¸ão  entre si, não houve
diferenc¸a  estatística quanto à condroprotec¸ão.
Conclusão:  os ácidos hialurônicos testados obtiveram efeito condroprotetor, sem diferenc¸a
estatística  com relac¸ão  aos diferentes pesos moleculares.
©  2014 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
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bntroduction
steoarthrosis (OA) is the most common joint disease world-
ide,  with prevalence greater than 10% after the age of 50.
his  condition exhibits cartilaginous histological changes, and
an  result in signiﬁcant functional limitation.1,2 OA is the
esult  of several factors in joint dysfunction and is charac-
erized  by cartilaginous degeneration and simultaneous bone,
artilage  and connective tissue proliferation.3 Among various
reatment  modalities currently available, the treatment with
ntra-articular  injections of hyaluronic acid (HA) has shown
eneﬁcial  effects in controlling the symptoms of knee OA.4
HA, a polysaccharide of the glycosaminoglycan family,
ontributes to the homeostasis of the normal articulation,
howing lower concentration and decreased molecular weight
n  the synovial ﬂuid in joints with osteoarthrosis.5,6 HA admin-
stered  in the form of intra-articular injections may  enhance
he  regenerative effects of endogenous HA on joint cartilage,
estore  the viscoelasticity of the synovial ﬂuid, contributing to
he synthesis of HA by synoviocytes, and prevent the degra-
ation  of proteoglycans and collagen ﬁbers present in the
xtracellular matrix. HA stimulates the metabolism, prevents
poptosis  of chondrocytes, and inhibits chondral degradation
nd  articular inﬂammatory responses.6 These effects of ther-
py  with the use of HA are attributed not only to its ability to
lleviate  the symptoms related to osteoarthrosis, but also to
ts interference in the progression of joint degeneration.5–7
Considering the scope and implications of the knee OA,
owadays we  understand the importance of diagnosis and
reatment  in its early stages, so that its consequences are
inimized.8 So far, there is no interventions capable of
nhibiting its evolution; hence, are essential options that allow
educing  its progression. Intra-articular injections of different
ypes  of HA could be used for this purpose.
To evaluate the effects of these substances in gonarthrosis,
n  this research we  proposed the use of an experimental OA
odel  that resembles that mimics the condition in humans.
he  section of the anterior cruciate ligament (ACL) of the rab-
it  knee, the “stiﬂe joint” (term used in veterinary anatomyEditora Ltda. 
for the joint similar to human knee in small animals, such as
rabbits  and dogs), mimics the morphological and biochemical
changes observed in human osteoarthrosis, which allows the
accurate  reproduction of the results.9,10
The aim of this study was to evaluate the effect of intra-
articular injections of native HA (Polireumin®, TRB Pharma,
São  Paulo, Brazil) and of branched-chain HA (Synvisc®, Novar-
tis,  São Paulo, Brazil), separately and comparatively between
themselves, in OA induced by ACL section of rabbit knees.
Materials  and  methods
This experiment was conducted at the bioterium of the post-
graduate  course of Federal University of Paraná (UFPR). The
Research  Ethics Committee of the Department of Health Sci-
ences,  UFPR, evaluated and approved the research protocol of
this  study (registry CEP/SD: 001.004 SI 06-06).
Forty-four male California rabbits, which were  kept before
and  during the procedures in cages (two animals per cage) in
the  unit bioterium, were used. The ration was  standardized
and  the animals received water ad libitum. The rabbits were
kept  under controlled light (light–dark cycle of 12 h), with tem-
perature  (22 ± 1 ◦C), humidity and noise level kept stable, with
an  average weight of 3.5 kg. Initially, all animals underwent
resection of the ACL. The right knee has been chosen just to
standardize  the experiment.
The  surgical procedure consisted of a pre-operative anes-
thesia  with 10 mg/kg of ketamine hydrochloride (Dopalen®)
and  50 mg/kg of xylazine hydrochloride (Anasedan®), admin-
istered  in the same syringe by intramuscular (IM) injection in
the semimembranosus and semitendinosus muscle bellies of
the  right hind limb. On the same occasion, the rabbits were
treated  with an injection of penicillin 14,400 IU and strepto-
mycin  6 mg (Pentabiotic Veterinary Reinforced® – Eurofarma)
as  antibiotic prophylaxis, and Flunamine® (Bayer) 2.2 mg/kg
Este é um artigo Open Access sob a licença de CC BY-NC-NDIM,  as post-operative analgesia.
The right knee was subjected to trichotomy and antisep-
sis  with polyvinylpyrrolidone (Povidini®). After application of
sterile  ﬁelds, a medial parapatellar incision was  made in the
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Fig. 3 – Photo of skin suture.Fig. 1 – Photo of the skin incision and ACL capsulotomy.
skin and subcutaneous tissue, followed by capsulotomy and
lateral  dislocation of the patella (Fig. 1). Then, the knee was
placed  in maximum ﬂexion, allowing visualization of the ante-
rior  cruciate ligament. This structure was  sectioned with an
scalpel  blade nr. 15 (Fig. 2), the joint was  irrigated with nor-
mal  saline; and a capsulorrhaphy and skin suture with 4.0
monoﬁlament nylon completed the operation (Fig. 3).
One  rabbit in Group 2 and one in Group 3 developed infec-
tion  of the surgical site with articular extension and were
excluded  from the study.
After surgery, the rabbits were  kept in their cages with-
out  restricting the support to operated members. The animals
were  randomized into three groups, with 14 animals in each
group.  After three weeks of the surgical procedure, the animals
were  initiated in their intra-articular injections. The amount
of  hyaluronic acid was  0.3 ml,  similar to the volume used in
small  joints of humans. Group P: control group, three injec-
tions  (at weekly intervals) of 0.9% isotonic saline; Group PR:
three  injections (at weekly intervals) of native hyaluronic acid
(Polireumin®); Group S: three injections at weekly intervals of
branched-chain  hyaluronic acid (Synvisc®).
Fig. 2 – Photo of ACL exposure.The rabbits were  euthanized after 12 weeks of surgery;
the  animals were  anesthetized as described previously
and subjected to intracardiac injection of thiopental (5 mL)
and  potassium chloride (10 mL). The tibial plateaus were
resected  aseptically and immersed in a ﬂask containing 10%
formaldehyde. The vials were labeled for identiﬁcation of
groups  and sent to the Clinical Pathology Service, Hospital de
Clínicas.
The tibial plateaus were  decalciﬁed. The medials in the area
of  greater cartilage thickness were  subjected to microtomy in
the sagittal plane; then, three slides were prepared by tibial
plateau,  with the use of stains Alcian Blue pH 1.0, Alcian Blue
pH  2.5, and Toluidine Blue and included in parafﬁn.
The stained slides were sent to the Polytechnic Center of
the  Life Sciences Sector, Federal University of Paraná.
The  histological slides were automatically scanned into a
ZeissImager  Metasystems Z2 microscope, using the software
MetaferMSearch with post-assembly with VSlide. Then, the
cartilaginous  regions were selected with the MetaViewer soft-
ware snapshot tool. The pictures were  analyzed by ImageJ
software, using the RGB Stack tool for Alcian Blue pH 1.0,
Alcian  Blue pH 2.5 and the Color Deconvolution “RGB” for Tolu-
idine  Blue stains. Subsequently, the percentage of marked area
was  calculated after a threshold, followed by quantiﬁcation.11
All study substances were acquired with own resources of
researchers,  without external ﬁnancial support.
Data obtained were  statistically analyzed by analysis of
variance  for single factor (ANOVA), followed by F and T
unpaired  tests, with signiﬁcance when p < 0.05. Graphs were
plotted  with the mean standard deviation, using the software
Microsoft Excel 2007. The data evaluation was  objective (stan-
dardized  by computer), and subjective, by scores given by the
biologist  responsible for the quantiﬁcation of the staining in
chi-square test. The scores 1, 2 and 3 were classiﬁed as poor,
intermediate and excellent.
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Table 1 – Numbers of quantiﬁcation of Toluidine Blue.
Slides Treatment groups
P PR S
1 66.81098 72.71096 96.52204
2  15.6544 50.25438 97.83475
3  48.30333 93.63707 73.56667
4  72.81427 98.97833 64.13119
5  76.35281 90.30573 49.14048
6  83.84236 73.03511 56.87234
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Table 3 – Numbers of quantiﬁcation of Alcian Blue pH
1.0.
Slides Treatment groups
P PR S
1 34.34797 68.02167 95.38368
2  89.68194 29.72821 97.26896
3  50.03834 81.88278 41.70293
4  41.21177 35.19409 68.65967
5  30.09164 34.54938 99.88211
6  38.7721 55.28347 44.2001
7  10.06779 43.21785 36.21376
8  32.54817 40.86236 29.08637
Table 4 – Numbers of quantiﬁcation of Alcian Blue pH
2.5.
Slides Treatment groups
P PR S
1 49.86103 61.96043 36.31462
2  37.0048 99.59628 96.2119
3  90.00677 89.87066 94.47586
4  39.21933 38.10635 63.63671
5  41.19301 99.1222 64.21882
6  35.90056 62.46105 60.28767  30.08729 96.62571 66.2721
8  37.47977 73.87755 46.77349
esults
he decalciﬁed slides, stained with Alcian Blue pH 1.0, Alcian
lue  pH 2.5, and Toluidine Blue, showed the presence of
lycosaminoglycans in larger quantities in the groups PR
Polireumin®) and S (Synvisc®) versus control group P (placebo).
he  signiﬁcance level for all analyzes was  5%.
The evaluation of the staining intensity of histological sec-
ions  stained with Alcian Blue pH 1.0, Alcian Blue pH 2.5 and
oluidine  Blue with ZeissImager Z2 Metasystems microscopy
enerated results that were  shown in tables and graphs. Below
re  graphs provided by the program,  representative of the
ctual  staining intensity measured in each group of the above-
entioned  dyes.
Through  the analysis conducted, each slide generated a
atum  in the set of data for each group: “P”, “PR”, or “S”,
otaling 24 slides/analyzed individuals (eight for each group).
or  the statistical analysis, the null hypothesis (H0) was:
here  is no difference between the independent variables,
nd  the alternative hypothesis (H1) was: There is difference
etween the independent variables. An alpha value of 0.05 was
sed.
The  values for each coloration are presented in Tables 1–4.
he  Kolmorogov–Smirnov test found a normal distribution
f  data (not shown). Thus, parametric tests were used: an
nalysis  of variance (ANOVA) for single factor and unpaired
tudent  t-test assumed equal variances. In the F-test, it was
ound  that the variances of the groups did not differ within the
ame  stain. In Toluidine Blue and Alcian Blue pH 2.5 (but not
or  pH 1.0) stains, ANOVA indicated a statistically signiﬁcant
Table 2 – Analyses of Table 1 data with Student’s t-test.
Information Com
P PR 
Mean 53.9 81.2 
Variance 607 277.4 
Observations 8 8 
Pooled variance 442.7 
H0 difference 0 
Df  14 
t-Calculated −2.6 
P  (T ≤ t) tailed 0.01 
t-Tailed critical 1.8 
P  (T ≤ t) two-tailed 0.02 
t-Two-tailed critical 2.1 7  12.16039 72.56529 64.85414
8  28.92869 53.91113 29.84288
difference (p < 0.05) (data not shown). Thus, for these two
dyes  with difference in ANOVA, Student’s t-tests were  per-
formed.  For Toluidine Blue staining, a difference was noted
only  between P versus PR groups (Table 2). For Alcian Blue pH
2.5,  a difference was  observed between P versus PR and P versus
S  groups, but the latter divergence was  perceived only in the
one-tailed  analysis (Table 5). In order to verify whether there
were  a difference between the values of P and S groups, non-
parametric  analysis for categorical variables was  performed.
For  this purpose, instead of analyzing the slides using the
ImageJ  software, scores from 1 to 3 for staining intensity were
attributed,  that is, the higher the score, the more  intense the
staining  with Alcian Blue pH 2.5, as described above.12The statistical test used was  the contingency chi-square
(2) test. For this test, H0 is: P and S groups did not differ in
the  pattern of staining intensity, while in H1′ P and S groups
parisons 2 × 2
P S PR S
53.9 68.9 81.2 68.9
608 382.3 277.4 382.3
8 8 8 8
495.1 329.8
0 0
14 14
−1.3 1.3
0.10 0.10
1.8 1.76131
0.20 0.20
2.1 2.1
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Table 5 – Analyses of Table 4 data with Student t test.
Information Comparisons 2 × 2
P PR P S PR S
Mean 41.8 72.2 41.8  63.7 72.2 63.7
Variance 499.7 497.8 499.7 559.1 497.8 559.1
Observations 8 8 8 8 8 8
Pooled variance 498.7 529.4 528.4
H0 difference 0 0 0
Df  14 14 14
t-Calculated −2.7 −1.9 0.7
P  (T ≤ t) tailed 0.01 0.04 0.2
t-Tailed critical 1.8 1.8 1.8
P  (T ≤ t) two-tailed 0.02 0.08 0.5
t-Two-tailed critical 2.1 
Table 6 – Analysis of categorical data of Alcian Blue pH
2.5.
Treatment groups Notes
1 2 3
P (n = 8) 62.5% (5) 12.5% (1) 25% (2)
S  (n = 8) 25% (2) 12.5% (1) 62.5% (5)
the  presence of glycosaminoglycans in greater amounts, when
compared  with the control group P (placebo). This ﬁnding con-Note: 2 calculated = 32.14286.
differ in the pattern of staining intensity. N = 16 (eight for each
treatment  group), alpha = 0.05, degree of freedom = 2, and tab-
ulated  2 = 5.991. 2 calculated was  = 32.14286 (Table 6). As the
calculated  value of 2 is greater than the tabulated value, we
reject  H0 and accept the alternative hypothesis.
Discussion
In recent decades, studies comparing the effectiveness of
hyaluronic  acids of different molecular weights have been
published.  The data are discrepant because of its results
and  methods of evaluation.13 In clinical practice, the ortho-
pedic  surgeons have preferred the hyaluronic acid of high
molecular  weight for the treatment of osteoarthrosis, based
on  studies such as Atamaz et al.14 and Wobig et al.15 who
used  the model of osteoarthrosis in humans, compared
hyaluronic acids of different molecular weights with saline
intra-articularly inﬁltrated, and obtained better results with
the  use of hyaluronic acid of higher molecular weight by clin-
ical  and non-histological criteria.
However, according to Karlsson et al.16 who studied
hyaluronic acids of different molecular weights injected by
intra-articular inﬁltrations in humans with osteoarthrosis,
there was  no signiﬁcant difference among hyaluronic acids
of  different molecular weights, concerning clinical and non-
histological  criteria.
These  controversies have led to the realization of this
study,  that compared the effect of a high molecular weight
® ®(Synvisc ) with a low weight (Polireumin ) hyaluronate. For
its  realization, we  used an experimental model of osteoarthro-
sis.2.1 2.1
The  experimental model in small animals which most
closely  resembles the osteoarthrosis present in human beings
is  the transection of the anterior cruciate ligament in rabbit
knee.  This model mimics the morphological and biochemi-
cal  changes observed in humans with osteoarthrosis.5 The
rabbit  was  the animal chosen because of its easy handling,
lower  cost, and the vast literature that conﬁrms its use
for  the purposes of obtaining induced osteoarthrosis. The
study  period of 12 weeks is relatively short for obtaining
AO, but this average time is used in most published stud-
ies  in the literature. The anatomy of the rabbit knee is easy
to  dissect and allows visualization of the anterior cruci-
ate  ligament, which facilitates the surgical procedure of its
transection.9,10,17,18
In the present study, the handling of the animals and the
surgical  dissection of the rabbit knees were  easy to perform.
The  skin incision, the medial capsulotomy with visualization
of  the anterior cruciate ligament, and its transection had been
done  quickly and in a practical way.  The knee plateaus under-
going  this procedure showed signs of obvious macroscopic
lesions, especially those in the control group P (placebo – 0.9%
saline).19
Speciﬁc histological colorations for glycosaminoglycans
were chosen to assess joint cartilage, because of their high
sensitivity  for detection of proteoglycans. Alcian Blue pH 1.0,
Alcian  Blue pH 2.5 and Toluidine Blue have great ability to stain
glycosaminoglycans and proteoglycans, having been used
successfully  in several histological studies of cartilage.20–23
The Alcian Blue pH 1.0 stains generally glycosaminoglycans
in different tissues, whereas Alcian Blue pH 2.5 and Toluidine
Blue  speciﬁcally stain proteoglycans.
The use of the ZeissImager Z2 Metasystems microscope
and of the MetaferMsearch software allowed the measure-
ment  of the staining intensity in the slides of cartilaginous
tissue.
Greater staining intensity was  obtained In S (Synvisc®) and
PR  (Polireumin®) groups versus control group P (placebo – 0.9%
saline);  hence, the decalciﬁed and stained slides with Alcian
Blue  pH 1.0, Alcian Blue pH 2.5 and Toluidine Blue showedﬁrms  the hypothesis that the hyaluronic acids tested act as
chondroprotective factors, as they preserved a greater amount
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10.  Sah RL, Yang AS, Chen AC, Hant JJ, Halili RB, Yoshioka M, et al.r e v b r a s o r t o p
f proteoglycans in the cartilaginous tissue of the knees inﬁl-
rated  with hyaluronates.
There  were  no statistical differences in the intensity of
taining  of slides of knees treated with inﬁltration with high
olecular  weight versus low molecular weight hyaluronic acid.
he transposition of the data found in rabbits in this study may
ot  reﬂect the same ﬁndings in humans.
At the same time, an evaluation of the staining intensity by
irect  vision of the slides, that is, dependent on the examiner,
as  done. In this sense, we asked a biologist to assess the
lides,  ascribing scores. This professional rated with 1, 2, and
 points the slides stained with Alcian Blue pH 2.5 as poor,
ntermediate and excellent, respectively. The results by direct
ision  conﬁrmed the results conferred by the instrument, i.e.,
here  was no statistical difference between the groups treated
ith  hyaluronates when compared with the placebo group,
nd  there was  no statistical difference between the groups
nﬁltrated with hyaluronates, regardless of molecular weight.
ubjective  data were  evaluated by chi-square test.
The  literature that compares the different molecular
eights of hyaluronates in this experimental model is scarce.
himizu  et al.24 in a study in rabbits, concluded that hyaluronic
cids  of low molecular weight were superior versus those of
igher  molecular weight. Their study did not mention the
ose  used in the inﬁltration; hence we could not make a
ore  appropriate comparison with our study. In our study, the
abbits  were  treated with intra-articular applications for three
eeks  (as is usually done in humans) and the volume used
as  0.3 mL  for the three substances tested (native hyaluronic
cid,  branched-chain hyaluronic acid, and normal saline). The
alf-life  of native hyaluronic acid is 13 h, while branched-
hain hyaluronic acid is 36 h. We chose a volume of 0.3 mL,
ecause  this is the recommended dose for use in small joints
f  humans.25
Ghosh and Guidolin26 using an experimental model of tran-
ection  of the anterior cruciate ligament in dogs, obtained
etter  results with hyaluronic acids of lower molecular weight.
he  same authors, in an in vitro study, found better results
ith  the use of hyaluronic acid of higher molecular weight,
hich  contradicted their studies in animals. This substance
ould  be a better stimulator of the production of extracellular
atrix components. This could be partly explained, because
he  hyaluronic acid of lower molecular weight would penetrate
he  extracellular matrix more  easily, maximize its concen-
ration,  and promote its interaction with target cells in the
ynovium.  Furthermore, there is evidence that the binding of
olecules  of hyaluronic acid with cellular receptors is depend-
nt  on the molecular weight.12,13
There are several hypotheses trying to explain the mech-
nism  of action of hyaluronic acids in non-pathological
rticulations of humans. In one of them, hyaluronic acid
ould  act as modulator, through the interaction with
D44  receptors present in synoviocytes, and would act
iochemically in the joint and decrease the production
f  cytokines, prostaglandins and metalloproteinases.27–30
rguably, hyaluronic acid also retrieves the physiological
roperties of synovial ﬂuid, decreases the pressure of the
trength/weight, and improves the distribution of the weight
ncident  on the joint. Therefore, hyaluronic acids play an
mportant  role in the mechanical effects of the joints.31 4;4 9(1):62–68  67
In summary, in this study the data conﬁrm the ﬁndings
of  Karlsson et al.16 who studied the effects of hyaluronates
of different molecular weights in intra-articular inﬁltrations
in  humans with osteoarthrosis, and suggest no differences
in  the molecular weight of hyaluronic acids, with respect to
chondroprotection.
Conclusion
The analysis of the effects of native and branched-chain
hyaluronic acids in an experimental model of osteoarthrosis
in  rabbits demonstrated chondroprotective proprieties, when
compared  to the control group (0.9% saline). When native
chain  and branched-chain hyaluronic acids were  compared,
no  statistically signiﬁcant difference was perceived.
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